- Full Year 2023 Biomerieux SA Earnings Call TranscriptMar 14, 2024€97.44 (-1.64%)Earnings
- Q3 2023 Biomerieux SA Corporate Sales Call TranscriptOct 26, 2023
- Half Year 2023 Biomerieux SA Earnings Call TranscriptSep 01, 2023€97.94Earnings
- Biomerieux SA Evolution of Biomerieux's Governance Call TranscriptJun 14, 2023
- Q1 2023 Biomerieux SA Corporate Sales Call TranscriptApr 27, 2023
- Full Year 2022 Biomerieux SA Earnings Call TranscriptMar 08, 2023€91.32 (-0.85%)Earnings
- Q3 2022 Biomerieux SA Corporate Sales Call TranscriptOct 26, 2022
- Half Year 2022 Biomerieux SA Earnings Call TranscriptAug 31, 2022€90.36 (-6.59%)Earnings
- Q1 2022 Biomerieux SA Business Results Call TranscriptApr 12, 2022
- Full Year 2021 Biomerieux SA Earnings Call TranscriptMar 02, 2022€96Earnings
- Q3 2021 Biomerieux SA Business Review Call TranscriptOct 21, 2021
- Half Year 2021 Biomerieux SA Earnings Call TranscriptSep 01, 2021€108.45 (+4.68%)Earnings
- Q1 2021 Biomerieux SA Business Review TranscriptApr 27, 2021
- Full Year 2020 Biomerieux SA Earnings Call TranscriptFeb 24, 2021€108.9 (+0.83%)Earnings
- Q3 2020 Biomerieux SA Business Review Call TranscriptOct 22, 2020
- Half Year 2020 Biomerieux SA Earnings Call TranscriptSep 02, 2020Earnings
- Q1 2020 Biomerieux SA Corporate Sales Call TranscriptApr 16, 2020
- Full Year 2019 Biomerieux SA Earnings Call TranscriptFeb 26, 2020Earnings
- Q3 2019 Biomerieux SA Business Review Call TranscriptOct 22, 2019
- Half Year 2019 Biomerieux SA Earnings Call TranscriptSep 04, 2019Earnings
- Q1 2019 Biomerieux SA Corporate Sales Call TranscriptApr 24, 2019
- Full Year 2018 Biomerieux SA Earnings Call TranscriptFeb 27, 2019Earnings
Full Year 2023 Biomerieux SA Earnings Call Transcript
Good day, and welcome to the bioMérieux FY 2023 Results Webcast. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Aymeric Fichet. Please go ahead.
Thanks a lot. Good afternoon, everyone, and thank you for joining us to review the bioMérieux performance for the 2023 full year results. I'm on line with Pierre Boulud, CEO; and Guillaume Bouhours, CFO. Please note that this conference call will include forward-looking statements, which are based entirely or partially on assessments or judgments that may change or be modified due to uncertainties and risks related to the company's environment, notably those described in the 2022 universal registration document. I also remind you that today's call is being recorded and that a replay will be available on our website, www.biomerieux-finance.com.
I will now hand the call over to Pierre and then we'll open the call to discussion and questions. Pierre, the floor is yours.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)